|
|
Article: NEW THERAPY SHUTS DOWN ALLERGIC REACTIONS
- Article from:
- United Press International
- Article date:
- April 30, 2002
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
00-00-0000
New therapy shuts down allergic reactions
LOS ANGELES, Apr 30, 2002 (United Press International via COMTEX)
-- An experimental therapy to freeze the molecular process that triggers
allergic reactions is showing promise in animal studies and could
be a potential treatment for humans, researchers reported Tuesday.
Researchers at the University of California at Los Angeles and the
University of New Mexico designed a genetically engineered molecule
called GE2 that interacts with two types of immune system cells playing
key roles in allergic reactions -- basophils and mast cells. The cells
respond abnormally to substances such as pollen or animal dander and
cause the ...